Sign In

Login

Password

Forgot Password ? Sign Up

Reverse cholesterol transport (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Reverse cholesterol transport" in English language version.

refsWebsite
Global rank English rank
15nih.gov
4th place
4th place
13doi.org
2nd place
2nd place
2worldcat.org
5th place
5th place
2semanticscholar.org
11th place
8th place
1nature.com
234th place
397th place
1wiley.com
222nd place
297th place

doi.org

  • Huang, LH; Elvington, A; Randolph, GJ (September 2015). "The role of the lymphatic system in cholesterol transport". Frontiers in Pharmacology. 6 (182): 182. doi:10.3389/fphar.2015.00182. PMC 4557107. PMID 26388772.
  • Pownall, Henry J.; Rosales, Corina; Gillard, Baiba K.; Gotto, Antonio M. (October 2021). "High-density lipoproteins, reverse cholesterol transport and atherogenesis". Nature Reviews Cardiology. 18 (10): 712–723. doi:10.1038/s41569-021-00538-z. ISSN 1759-5010.
  • Sacher, Sukriti; Mukherjee, Abhishek; Ray, Arjun (2023). "Deciphering structural aspects of reverse cholesterol transport: mapping the knowns and unknowns". Biological Reviews. 98 (4): 1160–1183. doi:10.1111/brv.12948. ISSN 1469-185X.
  • Rhainds D, Brissette L (January 2004). "The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders". The International Journal of Biochemistry & Cell Biology. 36 (1): 39–77. doi:10.1016/s1357-2725(03)00173-0. PMID 14592533.
  • Hafiane A, Gasbarrino K, Daskalopoulou SS (2019). "The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism". Metabolism: Clinical and Experimental. 100: 153953. doi:10.1016/j.metabol.2019.153953. PMID 31377319. S2CID 203413137.
  • Razavi, AC; Jain, V; Grandhi, GR; Patel, P; Karagiannis, A; Patel, N; Dhindsa, DS; Liu, C; Desai, SR; Almuwaqqat, Z; Sun, YV; Vaccarino, V; Quyyumi, AA; Sperling, LS; Mehta, A (18 January 2024). "Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?". The Journal of Clinical Endocrinology and Metabolism. 109 (2): 321–332. doi:10.1210/clinem/dgad406. PMC 11032254. PMID 37437107.
  • Khera, AV; Cuchel, M; de la Llera-Moya, M; Rodrigues, A; Burke, MF; Jafri, K; French, BC; Phillips, JA; Mucksavage, ML; Wilensky, RL; Mohler, ER; Rothblat, GH; Rader, DJ (13 January 2011). "Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis". The New England Journal of Medicine. 364 (2): 127–35. doi:10.1056/NEJMoa1001689. PMC 3030449. PMID 21226578.
  • Schandelmaier S, Briel M, Saccilotto R, Olu KK, Arpagaus A, Hemkens LG, Nordmann AJ (June 2017). "Niacin for primary and secondary prevention of cardiovascular events". The Cochrane Database of Systematic Reviews. 2017 (6): CD009744. doi:10.1002/14651858.CD009744.pub2. PMC 6481694. PMID 28616955.
  • Rubic T, Trottmann M, Lorenz RL (February 2004). "Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin". Biochemical Pharmacology. 67 (3): 411–9. doi:10.1016/j.bcp.2003.09.014. PMID 15037193.
  • Malik S, Kashyap ML (November 2003). "Niacin, lipids, and heart disease". Curr Cardiol Rep. 5 (6): 470–6. doi:10.1007/s11886-003-0109-x. PMID 14558989. S2CID 27918392.
  • Brownell, N; Rohatgi, A (August 2016). "Modulating cholesterol efflux capacity to improve cardiovascular disease". Current Opinion in Lipidology. 27 (4): 398–407. doi:10.1097/MOL.0000000000000317. PMID 27213627.
  • Rotllan, Noemí; Llaverías, Gemma; Julve, Josep; Jauhiainen, Matti; Calpe-Berdiel, Laura; Hernández, Cristina; Simó, Rafael; Blanco–Vaca, Francisco; Escolà-Gil, Joan Carles (February 2011). "Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1811 (2): 104–110. doi:10.1016/j.bbalip.2010.11.006. PMID 21126601.
  • Yamashita S, Masuda D, Matsuzawa Y (August 2015). "Did we abandon probucol too soon?". Current Opinion in Lipidology. 26 (4): 304–16. doi:10.1097/MOL.0000000000000199. PMID 26125504.

nature.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Huang, LH; Elvington, A; Randolph, GJ (September 2015). "The role of the lymphatic system in cholesterol transport". Frontiers in Pharmacology. 6 (182): 182. doi:10.3389/fphar.2015.00182. PMC 4557107. PMID 26388772.
  • Rhainds D, Brissette L (January 2004). "The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders". The International Journal of Biochemistry & Cell Biology. 36 (1): 39–77. doi:10.1016/s1357-2725(03)00173-0. PMID 14592533.
  • Hafiane A, Gasbarrino K, Daskalopoulou SS (2019). "The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism". Metabolism: Clinical and Experimental. 100: 153953. doi:10.1016/j.metabol.2019.153953. PMID 31377319. S2CID 203413137.
  • Razavi, AC; Jain, V; Grandhi, GR; Patel, P; Karagiannis, A; Patel, N; Dhindsa, DS; Liu, C; Desai, SR; Almuwaqqat, Z; Sun, YV; Vaccarino, V; Quyyumi, AA; Sperling, LS; Mehta, A (18 January 2024). "Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?". The Journal of Clinical Endocrinology and Metabolism. 109 (2): 321–332. doi:10.1210/clinem/dgad406. PMC 11032254. PMID 37437107.
  • Khera, AV; Cuchel, M; de la Llera-Moya, M; Rodrigues, A; Burke, MF; Jafri, K; French, BC; Phillips, JA; Mucksavage, ML; Wilensky, RL; Mohler, ER; Rothblat, GH; Rader, DJ (13 January 2011). "Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis". The New England Journal of Medicine. 364 (2): 127–35. doi:10.1056/NEJMoa1001689. PMC 3030449. PMID 21226578.
  • Schandelmaier S, Briel M, Saccilotto R, Olu KK, Arpagaus A, Hemkens LG, Nordmann AJ (June 2017). "Niacin for primary and secondary prevention of cardiovascular events". The Cochrane Database of Systematic Reviews. 2017 (6): CD009744. doi:10.1002/14651858.CD009744.pub2. PMC 6481694. PMID 28616955.
  • Rubic T, Trottmann M, Lorenz RL (February 2004). "Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin". Biochemical Pharmacology. 67 (3): 411–9. doi:10.1016/j.bcp.2003.09.014. PMID 15037193.
  • Malik S, Kashyap ML (November 2003). "Niacin, lipids, and heart disease". Curr Cardiol Rep. 5 (6): 470–6. doi:10.1007/s11886-003-0109-x. PMID 14558989. S2CID 27918392.
  • Brownell, N; Rohatgi, A (August 2016). "Modulating cholesterol efflux capacity to improve cardiovascular disease". Current Opinion in Lipidology. 27 (4): 398–407. doi:10.1097/MOL.0000000000000317. PMID 27213627.
  • Rotllan, Noemí; Llaverías, Gemma; Julve, Josep; Jauhiainen, Matti; Calpe-Berdiel, Laura; Hernández, Cristina; Simó, Rafael; Blanco–Vaca, Francisco; Escolà-Gil, Joan Carles (February 2011). "Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1811 (2): 104–110. doi:10.1016/j.bbalip.2010.11.006. PMID 21126601.
  • Yamashita S, Masuda D, Matsuzawa Y (August 2015). "Did we abandon probucol too soon?". Current Opinion in Lipidology. 26 (4): 304–16. doi:10.1097/MOL.0000000000000199. PMID 26125504.

ncbi.nlm.nih.gov

  • Huang, LH; Elvington, A; Randolph, GJ (September 2015). "The role of the lymphatic system in cholesterol transport". Frontiers in Pharmacology. 6 (182): 182. doi:10.3389/fphar.2015.00182. PMC 4557107. PMID 26388772.
  • Razavi, AC; Jain, V; Grandhi, GR; Patel, P; Karagiannis, A; Patel, N; Dhindsa, DS; Liu, C; Desai, SR; Almuwaqqat, Z; Sun, YV; Vaccarino, V; Quyyumi, AA; Sperling, LS; Mehta, A (18 January 2024). "Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?". The Journal of Clinical Endocrinology and Metabolism. 109 (2): 321–332. doi:10.1210/clinem/dgad406. PMC 11032254. PMID 37437107.
  • Khera, AV; Cuchel, M; de la Llera-Moya, M; Rodrigues, A; Burke, MF; Jafri, K; French, BC; Phillips, JA; Mucksavage, ML; Wilensky, RL; Mohler, ER; Rothblat, GH; Rader, DJ (13 January 2011). "Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis". The New England Journal of Medicine. 364 (2): 127–35. doi:10.1056/NEJMoa1001689. PMC 3030449. PMID 21226578.
  • Schandelmaier S, Briel M, Saccilotto R, Olu KK, Arpagaus A, Hemkens LG, Nordmann AJ (June 2017). "Niacin for primary and secondary prevention of cardiovascular events". The Cochrane Database of Systematic Reviews. 2017 (6): CD009744. doi:10.1002/14651858.CD009744.pub2. PMC 6481694. PMID 28616955.

semanticscholar.org

api.semanticscholar.org

wiley.com

onlinelibrary.wiley.com

worldcat.org

search.worldcat.org